Cytokinetics (CYTK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CYTK Cytokinetics

Watchlist

56.815
+1.315+2.37%

Trading Nov 7 13:39 ET

6.68BMarket Cap-10560P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Piper Sandler Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $107
Moomoo NewsNov 7 08:39 ET · Ratings
BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Maintains Target Price $60
Moomoo NewsNov 7 08:39 ET · Ratings
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $60 to $120
Moomoo NewsNov 7 08:00 ET · Ratings
Cytokinetics Hold Rating: Balancing Progress and Challenges Amid Uncertain Upside
TipRanksNov 7 06:52 ET · Ratings
Cytokinetics Q3 Loss Widens, Revenue Rises
MT NewswiresNov 7 05:59 ET
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Sarepta Therapeutics (SRPT) and Cytokinetics (CYTK)
TipRanksNov 7 05:40 ET · Ratings

Comments

Mr Long Term

Aug 13 17:42

Columns Top Calls on Wall Street: Starbucks, Dell, Warner Bros. and More.

Top 5 Upgrades:
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...